首页> 外文期刊>Molecular Therapy - Methods & Clinical Development >Barcoding of Macaque Hematopoietic Stem and Progenitor Cells: A Robust Platform to Assess Vector Genotoxicity
【24h】

Barcoding of Macaque Hematopoietic Stem and Progenitor Cells: A Robust Platform to Assess Vector Genotoxicity

机译:猕猴茎和祖细胞的条形码:评估载体遗传毒性的强大平台

获取原文
       

摘要

Gene therapies using integrating retrovirus vectors to modify hematopoietic stem and progenitor cells have shown great promise for the treatment of immune system and hematologic diseases. However, activation of proto-oncogenes via insertional mutagenesis has resulted in the development of leukemia. We have utilized cellular bar coding to investigate the impact of different vector designs on the clonal behavior of hematopoietic stem and progenitor cells (HSPCs) during in?vivo expansion, as a quantitative surrogate assay for genotoxicity in a non-human primate model with high relevance for human biology. We transplanted two rhesus macaques with autologous CD34+ HSPCs transduced with three lentiviral vectors containing different promoters and/or enhancers of a predicted range of genotoxicities, each containing a high-diversity barcode library that uniquely tags each individual transduced HSPC. Analysis of clonal output from thousands of individual HSPCs transduced with these barcoded vectors revealed sustained clonal diversity, with no progressive dominance of clones containing any of the three vectors for up to almost 3?years post-transplantation. Our data support a low genotoxic risk for lentivirus vectors in HSPCs, even those containing strong promoters and/or enhancers. Additionally, this flexible system can be used for the testing of future vector designs.
机译:使用整合逆转录病毒载体来改变造血干细胞和祖细胞的基因疗法对免疫系统和血液学疾病的治疗表现出了很大的希望。然而,通过插入诱变激活原型诱发导致白血病的发育。我们利用蜂窝条编码来研究不同载体设计对在血管生成茎和祖细胞(Hspcs)的克隆行为的影响,作为在具有高相关性的非人灵长类动物模型中的遗传毒性的定量替代试验对于人类生物学。我们用自体CD34 + HSPC移植两个恒河猴,用含有不同启动子的三个慢病毒载体和/或预测范围的遗传毒素的增强剂,每个伴随的遗传毒素的增强剂含有高分子条形码库,其唯一标记每个单独的转导HSPC。从这些条形码载体转导的数千个单独的HSPC的克隆输出揭示了持续的克隆多样性,克隆没有含有三种载体中的任何克隆的累进统治性,其后移植后几年。我们的数据支持HSPCS中的Lentivirus载体的低遗失毒性风险,甚至含有强促进剂和/或增强剂的载体。此外,这种灵活的系统可用于测试未来的矢量设计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号